Overview

Bioequivalence of Duvelisib and Food Effect on Pharmacokinetics of IPI-145

Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
To Evaluate the Bioequivalence of the two formulations of IPI-145 and the Effect of Food on the Pharmacokinetics of IPI-145
Phase:
Phase 1
Details
Lead Sponsor:
Infinity Pharmaceuticals, Inc.
SecuraBio